Q4 2025 earnings call recap: bioprocessing strength, margin trends, and 2026 guidance (3–6% growth, $8.35–$8.50 EPS).

The decision follows a high-level review by the subject expert committee for vaccines, which raised an alarm over the safety ...

During the Q&A session, Mike and Jon will be joined by our Chief Medical Officer, Dr. Ken Stein. Please note that on the call, operational revenue excludes the impact of foreign currency fluctuations, ...

Q4 2025 Earnings Call January 28, 2026 8:00 AM ESTCompany ParticipantsJohn Bedford - Vice President of Investor ...

Hypertension is a chronic disease with an incidence of more than 65 million people in the US (1). According to recent estimates nearly one in three US adults have high blood pressure (1). This chronic ...

At Healthline, we’re committed to providing you with trustworthy, accessible, and accurate information so you’re equipped to care for your health and wellness. We use an established Editorial Process ...

Trump says he doesn't know if he backs constitutional due process rights in new interview President Donald Trump is circumspect about his duties to uphold due process rights laid out in the ...